Stockscreener 앱 받기
12.72
1.52%
0.19
시간 외 거래:
12.72
전일 마감가:
$12.53
열려 있는:
$12.38
하루 거래량:
1.13M
Relative Volume:
1.83
시가총액:
$1.20B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-0.08%
1개월 성능:
-15.09%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$11.67
$13.32
1주일 범위
$11.67
$13.76
52주 변동 폭
$9.965
$19.45
Lumexa Imaging Holdings Inc Stock (LMRI) Company Profile
Compare LMRI vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LMRI
Lumexa Imaging Holdings Inc
|
12.72 | 1.18B | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Lumexa Imaging Holdings Inc Stock (LMRI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-09 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2026-01-05 | 개시 | Barclays | Overweight |
| 2026-01-05 | 개시 | Deutsche Bank | Buy |
| 2026-01-05 | 개시 | JP Morgan | Overweight |
| 2026-01-05 | 개시 | Jefferies | Buy |
| 2026-01-05 | 개시 | Leerink Partners | Outperform |
| 2026-01-05 | 개시 | Raymond James | Outperform |
| 2026-01-05 | 개시 | Wells Fargo | Overweight |
| 2026-01-05 | 개시 | William Blair | Outperform |
모두보기
Lumexa Imaging Holdings Inc 주식(LMRI)의 최신 뉴스
Auna S.A. Sees Strong Gains From Peru: More Upside on the Horizon - TradingView
Top Lumexa Imaging (LMRI) Competitors 2026 - MarketBeat
LMRI Stock Price, Quote & Chart | LUMEXA IMAGING HOLDINGS INC (NASDAQ:LMRI) - ChartMill
Is It Time To Revisit Lumexa Imaging Holdings (LMRI) After Recent Healthcare Sector Focus? - simplywall.st
Is Lumexa Imaging Holdings (LMRI) Pricing Look Misaligned After Recent Imaging Sector Attention - Yahoo Finance
LMRI: Advanced imaging and technology fuel strong growth, with expansion and transparency prioritized - TradingView
Lumexa Imaging Holdings, Inc. (LMRI) Presents at Leerink Global Healthcare Conference 2026Slideshow - Seeking Alpha
Lumexa Imaging Holdings, Inc.: Shareholders Board Members Managers and Company Profile | US5502491062 - marketscreener.com
A Look At Lumexa Imaging Holdings (LMRI) Valuation After Recent Share Price Strength - simplywall.st
Lumexa Imaging Holdings, Inc. (LMRI) Presents at 47th Annual Raymond James Institutional Investor ConferenceSlideshow (NASDAQ:LMRI) 2026-03-03 - Seeking Alpha
LMRI: Advanced imaging growth, JV expansion, and strong guidance highlight sector momentum - TradingView
Lumexa Imaging Reports Strong 2025 Results, Announces 2026 Financial Guidance and Growth Highlights - Minichart
Lumexa Imaging announces preliminary unaudited fourth quarter and full year 2025 results; provides 2026 financial guidance and earnings conference call date - marketscreener.com
Lumexa Imaging Announces Preliminary Unaudited Fourth Quarter And Full Year 2025 Results Provides 2026 Financial Guidance And Earnings Conference Call Date - TradingView
Lumexa Imaging Announces Strong Preliminary 2025 Financial Results - TipRanks
Lumexa Imaging Holdings, Inc. Provides Earnings Guidance for the Year Ending December 31, 2026 - marketscreener.com
Lumexa Imaging Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results; Provides 2026 Financial Guidance and Earnings Conference Call Date - Weekly Voice
Lumexa Imaging (LMRI) awards 12,414 RSUs to Principal Accounting Officer - Stock Titan
Raymond James Upgrades Lumexa Imaging Holdings, Inc. (LMRI) to Strong Buy with an Unchanged $23 Price Target - Bitget
Lumexa Imaging Holdings, Inc. (LMRI) stock news today: Live updates - Bitget
11 Newly-Listed NASDAQ Stocks to Buy Now - Insider Monkey
Lumexa Imaging earnings in focus as profitability test looms - Investing.com Australia
Lumexa Imaging earnings in focus as profitability test looms By Investing.com - Investing.com Canada
Lumexa Imaging Announces Participation in Upcoming Investor Conferences - Finviz
Wall Street Analysts Are Bullish on Top Technology Picks - The Globe and Mail
LMRI Lumexa Imaging Holdings, Inc. Common Stock Strong Buy Raymond James Feb 2026 - Meyka
Lumexa Imaging (NASDAQ:LMRI) Raised to "Strong-Buy" at Raymond James Financial - MarketBeat
Raymond James upgrades Lumexa Imaging stock to Strong Buy with $23 target - Investing.com Canada
FinancialContentLumexa Imaging Holdings, Inc.Common Stock (Nasdaq:LMRI) Stock Quote - FinancialContent
Lumexa Imaging's Dr. Jennifer L. Kemp Elected to RSNA Board, Advancing National Leadership in Quality and Patient-Centered Care - The Malaysian Reserve
Lumexa Imaging's Dr. Jennifer L. Kemp Elected to RSNA Board, Adv - GuruFocus
Lumexa Imaging’s Dr. Kemp elected to RSNA board By Investing.com - Investing.com Canada
Lumexa Imaging (LMRI) Institutional Ownership 2026 $LMRI - MarketBeat
Lumexa Imaging Holdings, Inc.’s Quiet Period Set To End on January 20th (NASDAQ:LMRI) - Defense World
Lumexa Imaging (LMRI) Stock Price, News & Analysis $LMRI - MarketBeat
Lumexa Imaging Holdings chief legal officer Julie Szeker to resign in March - Investing.com Nigeria
Lumexa Imaging Holdings, Inc. Announces Resignation of Chief Legal Officer and Corporate Secretary Julie Szeker, Effective March 13, 2026 - marketscreener.com
Lumexa Imaging Holdings chief legal officer Julie Szeker to resign in March By Investing.com - Investing.com South Africa
Lumexa Imaging Announces Chief Legal Officer Resignation - TipRanks
Assessing Lumexa Imaging Holdings (LMRI) Valuation After Recent Share Price Pullback - Yahoo Finance
LMRI: Global radiopharma leader drives growth with late-stage oncology pipeline and strategic expansion - TradingView — Track All Markets
Lumexa Imaging: Resilient Demand With Compounding Scale Moat (NASDAQ:LMRI) - Seeking Alpha
Lumexa Imaging Holdings, Inc.Common Stock (NQ: LMRI - FinancialContent
Lumexa Imaging Achieves Record De Novo Expansion in 2025 - Sahm
Lumexa Imaging Holdings, Inc.: Revenue and Earnings Analysts Forecasts Revisions | LMRI | US5502491062 - MarketScreener
Lumexa Imaging Holdings, Inc.: Target Price Consensus and Analysts Recommendations | LMRI | US5502491062 - MarketScreener
Lumexa Imaging Holdings, Inc.: Dividend historical data and projections - MarketScreener
Lumexa Imaging Holdings Inc (LMRI) 재무 분석
Lumexa Imaging Holdings Inc (LMRI)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):